Tumor cell hypoxia and the hypoxia-response signaling system as a target for prostate cancer therapy

Current Drug Targets

Volumn 4, Issue 3, 2003, Pages 191-196

  Anastasiadis, Aristotelis G ^a   Bemis, Debra L ^a   Stisser, Brian C ^a   Salomon, Laurent ^a   Ghafar, Mohamed A ^a   Buttyan, Ralph ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Akt Protein kinase B; Angiogenesis; Apoptosis; Hypoxia; Hypoxia inducible factor 1 (HIF 1 ); Prostate cancer; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; GENE PRODUCT; MITOMYCIN C; NITRATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TIRAPAZAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HIF 1ALPHA; TX 1102; TX 402; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADVANCED CANCER; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL GROWTH; CELL HYPOXIA; CELL SURVIVAL; DRUG TARGETING; EUKARYOTIC CELL; GENE EXPRESSION; HUMAN; MAMMAL CELL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VIRAL GENE THERAPY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; GENE THERAPY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037381870     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033491136     Document Type: Review

References (52)

1. Carmeliet, P.; Dor, Y.; Herbert, J.M.; Fukumura, D.; Brusselmans, K.; Dewerchin, M.; Neeman, M.; Bono, F.; Abramovitch, R.; Maxwell, P.; Koch, C.J.; Ratcliffe, P.; Moons, L.; Jain, R.K.; Collen, D.; Keshert, E. and Keshet, E. (1998) Nature, 394(6692), 485-490.
2. Folkman J. (1995) Nat. Med., 1(1), 27-31.
3. Bush, R.S.; Jenkin, R.D.; Allt, W.E.; Beale, F.A.; Bean, H.; Dembo, A.J. and Pringle, J.F. (1978) Br. J. Cancer Suppl., 37(3), 302-306.
4. Vaupel, P.; Thews, O. and Hoeckel, M. (2001) Med. Oncol., 18(4), 243-259.
5. Semenza, G.L. (2000) J. Appl. Physiol., 88(4), 1474-1480.
6. Semenza, G.L. (2001) Cell, 107(1), 1-3.
7. Semenza, G.L. (2001) Curr. Opin. Cell Biol., 13(2), 167-171.
8. Brahimi-Horn, C.; Berra, E. and Pouyssegur J. (2001) Trends Cell. Biol., 11(11), S32-S36.
9. Wang G.L. and Semenza G.L. (1995) J. Biol. Chem., 270(3), 1230-1237.
10. Huang, L.E.; Gu, J.; Schau, B. and Bunn, H.F. (1998) Proc. Natl. Acad. Sci. USA, 95(14), 7987-7992.
11. Jaakkola, P.; Mole, D.R.; Tian, Y.M.; Wilson, M.I.; Gielbert, J.; Gaskell, S.J.; Kriegsheim, A.V.; Hebestreit, H.F.; Mukherji, M.; Schofield, C.J.; Maxwell, P.H.; Pugh, C.W. and Ratcliffe, P.J. (2001) Science, 292(5516), 468-472.
12. Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J.M.; Lane, W.S. and Kaelin, W.G. Jr. (2001) Science, 292(5516), 464-468.
13. Mole, D.R.; Maxwell, P.H.; Pugh, C.W. and Ratcliffe, P.J. (2001) IUBMB Life, 52(1-2), 43-47.
14. Wang, G.L. and Semenza, G.L. (1993) J. Biol. Chem., 268(29), 21513-21518.
15. Semenza G.L. (2000) Biochem. Pharmacol., 59(1), 47-53.
16. Wang G.L.; Jiang B.-H.; Rue E.A. and Semenza G.L. (1995) Proc. Natl. Acad. Sci. USA, 92(12), 5510-5514.
17. Garayoa, M.; Martinez, A.; Lee, S.; Pio, R.; An, W.G.; Neckers, L.; Trepel, J.; Montuenga, L.M.; Ryan, H.; Johnson, R.; Gassmann, M. and Cuttitta F. (2000) Mol. Endocrinol., 14(6), 848-862.
18. Alvarez-Tejado, M.; Naranjo-Suarez, S.; Jimenez, C.; Carrera, A.C.; Landazuri, M.O. and del Peso, L. (2001) J. Biol. Chem., 276(25), 22368-22374.
19. Vivanco, I. and Sawyers, C.L. (2002) Nat. Rev. Cancer, 2(7), 489-501.
20. Ghafar, M.A.; Anastasiadis, A.G.; Chen, M.-W., Olsson, L.E., Xie, H.; Benson, M.C. and Buttyan, R. (2002) Prostate, In Press.
21. Zhong, H.; Chiles, K.; Feldser, D.; Laughner, E.; Hanrahan, C.; Georgescu, M.M.; Simons, J.W. and Semenza G.L. (2000) Cancer Res., 60(6), 1541-1545.
22. Minet, E.; Michel, G.; Mottet, D.; Raes, M. and Michiels, C. (2001) Free Radic. Biol. Med., 31(7), 847-855.
23. Movsas, B.; Chapman, J.D.; Horwitz, E.M.; Pinover, W.H.; Greenberg, R.E.; Hanlon, A.L.; Iyer R. and Hanks G.E. (1999) Urology, 53(1), 11-18.
24. Movsas, B.; Chapman, J.D.; Greenberg, R.E.; Hanlon, A.L.; Horwitz, E.M.; Pinover, W.H.; Stobbe, C. and Hanks, G.E. (2000) Cancer, 89(9), 2018-2024.
25. Cvetkovic, D.; Movsas, B.; Dicker, A.P.; Hanlon, A.L.; Greenberg, R.E.; Chapman, J.D.; Hanks, G.E. and Tricoli J.V. (2001) Urology, 57(4), 821-825.
26. Zhao, D.; Constantinescu, A.; Jiang, L.; Hahn, E.W. and Mason, R.P. (2001) Am. J. Clin. Oncol., 24(5), 462-466.
27. Zhong, H.; De Marzo, A.M.; Laughner, E.; Lim, M.; Hilton, D.A.; Zagzag, D.; Buechler, P.; Isaacs, W.B.; Semenza, G.L. and Simons J.W. (1999) Cancer Res., 59(22), 5830-5935.
28. Talks K.L.; Turley H.; Gatter K.C.; Maxwell P.H.; Pugh C.W.; Ratcliffe P.J. and Harris A.L. (2000) Am. J. Pathol., 157(2), 411-421.
29. Shabsigh, A.; Tanji, N.; D'Agati, V.; Rubin, M.; Goluboff, E.T.; Kiss, A.; Heitjan, D. and Buttyan, R. (1999) Endocrin., 140(4), 1920-1926.
30. Shabsigh, A.; Ghafar, M.A.; de la Taille, A.; Burchardt, M.; Kaplan, S.A.; Anastasiadis, A.G. and Buttyan R. (2001) J. Cell. Biochem., 81(3), 437-444.
31. Buttyan, R.; Ghafar, M.A. and Shabsigh, A. (2000) Curr. Opin. Urol., 10(5), 415-420.
32. Anastasiadis, A.; Ghafar, M.A.; Salomon, L.; Vacherot, F.; Benedit, P.; Chen, M.-W.; Shabsigh, A.; Burchardt, M.; Chopin, D.K., Shabsigh, R. and Buttyan R. (2002) Cancer Res. Clin. Oncol., 128(7), 358-362.
33. Patterson, LH. (1993) Cancer Metastasis Rev., 12(2), 119-134.
34. Brown, J.M. and Siim, B.G. (1996) Semin. Radiat. Oncol., 6(1), 22-36.
35. Denny, W.A. (2000) Lancet Oncol., 1(1), 25-29.
36. de Groot, F.M.; Damen, E.W. and Scheeren, H.W. (2001) Curr. Med. Chem., 8(9), 1093-1122.
37. Tomasz, M. and Palom, Y. (1997) Pharmacol. Ther., 76(1-3), 73-87.
38. Spanswick, V.J.; Cummings, J. and Smyth, J.F. (1998) Gen. Pharmac., 31(4), 539-544.
39. Belcourt, M.F.; Hodnick, W.F.; Rockwell, S. and Sartorelli, A.C. (1998) Adv. Enzyme Regul., 38, 111-133.
40. Iyer, V.N. and Szybalski, W. (1964) Science, 145(3627), 55-58.
41. Logothetis, C.J.; Samuels, M.L.; von Eschenbach, A.C.; Trindade, A.; Ogden, S.; Grant, C. and Johnson, D.E. (1983) J. Clin. Oncol., 1(6), 368-379.
42. Babaian, R.J. and Hsu, S.D. (1984) Urology, 23(3), 272-275.
43. Recchia, F.; Sica, G.; De Filippis, S.; Rosselli, M.; Pompili, P.L. and Rea, S. (2001) Am. J. Clin. Oncol., 24(4), 232-236.
44. Rischin, D.; Peters, L.; Hicks, R.; Hughes, P.; Fisher, R.; Hart, R.; Sexton, M.; D'Costa, I. and von Roemeling, R. (2001) J. Clin. Oncol., 19(2), 535-542.
45. Peters, LJ. (2001) Acta Oncol., 40(8), 937-940.
46. Nagasawa, H.; Yamashita, M.; Mikamo, N.; Shimamura, M.; Oka, S.; Uto, Y. and Hori, H. (2002) Comp. Biochem. Physiol. A. Mol. Integr. Physiol., 132(1), 33-40.
47. Nuyts, S.; Van Mellaert, L.; Theys, J.; Landuyt, W.; Lambin, P. and Anne, J. (2002) Anticancer Drugs, 13(2), 115-125.
48. Sioud, M. (2001) Curr. Mol. Med., 1(5), 575-588.
49. Chun, Y.S.; Choi, E.; Kim, T.Y.; Kim, M.S. and Park, J.W. (2002) Biochem. J, 362(Pt 1), 71-79.
50. Hur, E.; Chang, K.Y.; Lee, E.; Lee, S.-K. and Park, H. (2001) Mol. Pharmacol., 59(5), 1216-1224.
51. Rapisarda, A.; Uranchimeg, B.; Scudiero, D.A.; Selby, M.; Sausville, E.A.; Shoemaker, R.H. and Melillo, G. (2002) Cancer Res., 62(15), 4316-4324.
52. Ruan, H.; Su, H.; Hu, L.; Lamborn, K.R.; Kan, Y.W. and Deen, D.F. (2001) Neoplasia, 3(3), 255-263.